RecruitingNot Applicable

Diagnosis of Atrial Fibrillation in Postoperative Thoracic Surgery Using a Smartwatch

France302 participantsStarted 2025-06-01

Plain-language summary

Postoperative atrial fibrillation (POAF) occurs in approximately 20% of patients following thoracic surgery. Early diagnosis is essential to prevent complications such as heart failure, stroke, myocardial infarction, and increased mortality. Smartwatches equipped with single-lead ECG capabilities and algorithms to detect asymptomatic atrial fibrillation (AF) offer a potential solution. This study aims to evaluate the effectiveness of smartwatches in detecting POAF compared to standard care.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Adults (\>18 years old). * Patients undergoing major thoracic surgery with one-lung ventilation within the past 48 hours. * Scheduled pneumonectomy or lobectomy. * Admission to a conventional surgical unit postoperatively. * Ability to perform single-lead ECG using a smartwatch. * Coverage under a social security system. * Signed informed consent Exclusion Criteria: * History of atrial fibrillation. * Requirement for telemetry for AV block or tachyarrhythmias (\>140 bpm). * Dependency on a pacemaker. * Participation in another interventional clinical trial affecting POAF incidence. * Mediastinal, pleural, or chest wall surgery. * Reoperations or surgeries performed more than 48 hours prior. * Pregnant women. * Patients under guardians or similar legal protection.

What they're measuring

the incidence of POAF

Timeframe: at day 7

Trial details

NCT IDNCT06724718

SponsorCentre Hospitalier Universitaire, Amiens

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2027-07

Contact for this trial

Pierre Huette, MD

33322088371 Huette.pierre@chu-amiens.fr